Target intelligence / Profile preview

Melanoma Antigen Family A Member 3

Molecular classification
Cancer-testis antigen
01

Overview

MAGE-A3 is a cancer-testis antigen frequently expressed in a variety of malignancies but with highly restricted expression in normal adult tissues. Its overexpression promotes cell proliferation and survival through mechanisms such as TP53 suppression. It serves as a prognostic marker and a target for immunotherapeutic strategies, including vaccines and engineered T-cell therapies.

Other names
MAGE-A3CT1.3HIP8HYPDMAGEA6
02

Mechanism of action

Targeted by therapeutic vaccines and engineered T-cell therapies (TCRs or CARs) specific for HLA-restricted epitopes derived from the antigen.

03

Biological functions

Cell proliferationCell survivalTP53 suppressionRegulation of transcription factors
04

Disease associations

Cancer
05

Safety considerations

Potential for cross-reactivity of anti-MAGE-A3 TCRs with peptides from closely related proteins (e.g., EPS8L2, MAGE-A12).Variable clinical efficacy of vaccines targeting MAGE-A3.
06

Biomarkers

MAGE-A3 expression level in tumor tissue

Beyond the preview

Go deeper on Melanoma Antigen Family A Member 3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Melanoma Antigen Family A Member 3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call